GlaxoSmithKline and Harvard Stem Cell Institute Announce Major Collaboration Agreement
HarvardScience “GlaxoSmithKline (GSK) and Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25...HarvardScience
“GlaxoSmithKline (GSK) and Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.”
Read more »